511 related articles for article (PubMed ID: 30543320)
1. Experiences in fosfomycin susceptibility testing and resistance mechanism determination in Escherichia coli from urinary tract infections in the UK.
Cottell JL; Webber MA
J Med Microbiol; 2019 Feb; 68(2):161-168. PubMed ID: 30543320
[TBL] [Abstract][Full Text] [Related]
2. [Fosfomycin susceptibility of urinary Escherichia coli isolates producing extended-spectrum beta-lactamase according to CLSI and EUCAST recommendations].
Cağan Aktaş S; Gençer S; Batırel A; Hacıseyitoğlu D; Ozer S
Mikrobiyol Bul; 2014 Oct; 48(4):545-55. PubMed ID: 25492650
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility and mechanisms of fosfomycin resistance in extended-spectrum β-lactamase-producing Escherichia coli strains from urinary tract infections in Wenzhou, China.
Bi W; Li B; Song J; Hong Y; Zhang X; Liu H; Lu H; Zhou T; Cao J
Int J Antimicrob Agents; 2017 Jul; 50(1):29-34. PubMed ID: 28456703
[TBL] [Abstract][Full Text] [Related]
4. [In vitro activity of fosfomycin trometamol in the treatment of Escherichia coli related uncomplicated urinary tract infections].
Hoşbul T; Ozyurt M; Baylan O; Bektöre B; Ardiç N; Ceylan S; Erdemoğlu A; Haznedaroğlu T
Mikrobiyol Bul; 2009 Oct; 43(4):645-9. PubMed ID: 20084918
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ
J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
[TBL] [Abstract][Full Text] [Related]
6. Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands?
Knottnerus BJ; Nys S; Ter Riet G; Donker G; Geerlings SE; Stobberingh E
J Antimicrob Chemother; 2008 Aug; 62(2):356-9. PubMed ID: 18424789
[TBL] [Abstract][Full Text] [Related]
7. SUsceptibility and Resistance to Fosfomycin and other antimicrobial agents among pathogens causing lower urinary tract infections: findings of the SURF study.
Tutone M; Bjerklund Johansen TE; Cai T; Mushtaq S; Livermore DM
Int J Antimicrob Agents; 2022 May; 59(5):106574. PubMed ID: 35307561
[TBL] [Abstract][Full Text] [Related]
8. In-vitro susceptibility of quinolone-resistant clinical isolates of Escherichia coli to fosfomycin trometamol.
Ungheri D; Albini E; Belluco G
J Chemother; 2002 Jun; 14(3):237-40. PubMed ID: 12120876
[TBL] [Abstract][Full Text] [Related]
9. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
Oteo J; Orden B; Bautista V; Cuevas O; Arroyo M; Martínez-Ruiz R; Pérez-Vázquez M; Alcaraz M; García-Cobos S; Campos J
J Antimicrob Chemother; 2009 Oct; 64(4):712-7. PubMed ID: 19671590
[TBL] [Abstract][Full Text] [Related]
10. Emergence of fosfomycin resistance among isolates of Escherichia coli harboring extended-spectrum and AmpC β-lactamases.
Bahramian A; Eslami G; Hashemi A; Tabibi A; Heidary M
Acta Microbiol Immunol Hung; 2018 Mar; 65(1):15-25. PubMed ID: 29137487
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamic Evaluation of Fosfomycin against Escherichia coli and Klebsiella spp. from Urinary Tract Infections and the Influence of pH on Fosfomycin Activities.
Fedrigo NH; Mazucheli J; Albiero J; Shinohara DR; Lodi FG; Machado ACDS; Sy SKB; Tognim MCB
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607025
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
[TBL] [Abstract][Full Text] [Related]
13. Frequency and Mechanisms of Spontaneous Fosfomycin Nonsusceptibility Observed upon Disk Diffusion Testing of Escherichia coli.
Lucas AE; Ito R; Mustapha MM; McElheny CL; Mettus RT; Bowler SL; Kantz SF; Pacey MP; Pasculle AW; Cooper VS; Doi Y
J Clin Microbiol; 2018 Jan; 56(1):. PubMed ID: 29093108
[TBL] [Abstract][Full Text] [Related]
14. Urinary Tract Conditions Affect Fosfomycin Activity against Escherichia coli Strains Harboring Chromosomal Mutations Involved in Fosfomycin Uptake.
Martín-Gutiérrez G; Docobo-Pérez F; Rodriguez-Beltrán J; Rodríguez-Martínez JM; Aznar J; Pascual A; Blázquez J
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038268
[TBL] [Abstract][Full Text] [Related]
15. Potential role of fosfomycin in the treatment of community-acquired lower urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
Wilson DT; May DB
Am J Ther; 2013; 20(6):685-90. PubMed ID: 21768870
[TBL] [Abstract][Full Text] [Related]
16. Rapid detection of fosfomycin resistance in Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections.
Kansak N; Arıcı N; Adaleti R; Nakipoglu Y; Aksaray S
J Microbiol Methods; 2021 Sep; 188():106296. PubMed ID: 34333048
[TBL] [Abstract][Full Text] [Related]
17. Biological cost of fosfomycin resistance in Escherichia coli in a murine model of urinary tract infection.
Pourbaix A; Guérin F; Lastours V; Chau F; Auzou M; Boulley E; Cattoir V; Fantin B
Int J Med Microbiol; 2017 Dec; 307(8):452-459. PubMed ID: 28986014
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of O25b-ST131 clone and fosfomycin resistance in urinary Escherichia coli isolates and their relation to CTX-M determinant.
Demirci-Duarte S; Unalan-Altintop T; Eser OK; Cakar A; Altun B; Sancak B; Gur D
Diagn Microbiol Infect Dis; 2020 Sep; 98(1):115098. PubMed ID: 32603974
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterisation of fosfomycin resistance in Escherichia coli urinary tract infection isolates from Australia.
Mowlaboccus S; Daley D; Pang S; Gottlieb T; Merlino J; Nimmo GR; George N; Korman TM; Streitberg R; Robson J; Peachey G; Collignon P; Bradbury S; Colombi E; Ramsay JP; Rogers BA; Coombs GW
Int J Antimicrob Agents; 2020 Oct; 56(4):106121. PubMed ID: 32739475
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Accuracy Of Rapid Fosfomycin Np Test For Detection Of Fosfomycin Resistance In Escherichia Coli In A Tertiary Care Hospital In Pakistan.
Yunus F; Hussain A; Mirza IA; Hanif F; Hussain W; Satti L; Khursheed U
J Ayub Med Coll Abbottabad; 2021; 33(4):668-672. PubMed ID: 35124928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
